Ramaphosa hails Lenacapavir roll out as turning point in HIV fight
South Africa has launched the rollout of lenacapavir, a twice-yearly injectable HIV prevention drug. President Cyril Ramaphosa described the move as a turning point in the country's fight against the virus.
Why it matters
As the country with the highest HIV burden, this rollout represents a significant shift in public health strategy toward long-acting prevention.
A twice-yearly injectable HIV prevention drug has arrived in South Africa. The rollout of the drug, lenacapavir, is underway in the country that needs it the most, about a-year-and-a-half after US aid cuts hit some of its HIV programmes. South African President Cyril Ramaphosa told crowds gathered for its launch at Lilian Ngoyi stadium in Secunda, Mpumalanga province, that the introduction of lenacapavir was a turning point in South Africa’s fight against HIV.
The article balances government optimism with concerns from civil society regarding the scale of the rollout.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in